DEAD box 1: a novel and indepen ...
Breast cancer is a heterogeneous disease characterized by diverse molecular signatures and a variable response to therapy. Clinical management of br ...
Cytokeratin 5 positive cells re ...
A majority of breast cancers are estrogen receptor (ER) positive and have a luminal epithelial phenotype. However, these ER? tumors often contain h ...
Stimulation of retinoic acid-in ...
The sodium iodide symporter (NIS) mediates the active iodide uptake in the thyroid gland as well as lactating breast tissue. Recently, we reported s ...
Gene expression profile predict ...
Prognosis of early beast cancer is heterogeneous. Today, no histoclinical or biological factor predictive for clinical outcome after adjuvant anthra ...
Transient over-expression of es ...
Estrogen receptor-a (ERa) positive breast cancer frequently responds to inhibitors of ERa activity, such as tamoxifen, and/or to aromatase inhibitor ...
Functional implication of TRAIL ...
Recently, TRAIL function has been elucidated beyond its known classical role of mediating cellular homeostasis and immune surveillance against trans ...
Breast cancer prognostic marker ...
Historically, new prognostic markers for breast cancer were assessed separately and sequentially in a series of studies, often with considerable cos ...
Development of 95-gene classifi ...
Our aim was to develop an accurate diagnostic system using gene expression analysis by means of DNA microarray for prognosis of node-negative and es ...
Native MAG-1 antibody almost de ...
native form of mouse monoclonal IgG1 antibody called MAG-1, which recognizes an epitope on provasopressin, has been found to shrink and produce ext ...
Mediator of DNA damage checkpoi ...
The mediator of DNA damage checkpoint protein 1 (MDC1) regulates cell cycle checkpoints and recruits repair proteins to sites of double-stranded DNA ...
MPA-induced gene expression and ...
Over the past several years, we have been interested in understanding the mechanisms by which mammary carcinomas acquire hormone independence. We d ...
CTEN (C-terminal tensin-like), ...
C-terminal tensin-like (CTEN) gene is a member of the TENSIN gene family, involved in cell migration and localised at focal adhesion sites. This stu ...
Biological and clinical implica ...
Nicastrin is an essential component of the gamma secretase (GS) enzyme complex, required for its synthesis and recognition of substrates for proteol ...
MicroRNA-30c expression level i ...
MicroRNAs (miRNAs) are small RNA molecules that modulate gene expression and which have been implicated in cancer. We evaluated whether five candida ...
High-resolution analyses of gen ...
The advent of high-throughput technologies in molecular biology has dramatically increased our understanding of breast cancer during the past decade ...
The PHSCN dendrimer as a more p ...
The a5b1 integrin fibronectin receptor is an attractive therapeutic target in breast cancer because it plays key roles in invasion and metastasis. W ...
PALB2 analysis in BRCA2-like fa ...
BRCA2 and PALB2 function together in the Fanconi anemia (FA)–Breast Cancer (BRCA) pathway. Mono-allelic and bi-allelic BRCA2 and PALB2 mutation car ...
Trastuzumab-DM1 (T-DM1) retains ...
Trastuzumab (Herceptin) is currently used as a treatment for patients whose breast tumors overexpress HER2/ErbB2. Trastuzumab-DM1 (T-DM1, trastuzum ...
Hypermethylation of the progest ...
Most breast carcinomas that are estrogen receptor (ER) and progesterone receptor (PR) positive respond initially to an endocrine therapy, but over t ...
Ep-CAM RNA expression predicts ...
Epithelial cell adhesion molecule (Ep-CAM) recently received increased attention as a prognostic factor in breast cancer.We aimed to validate the in ...
Elevated TRF2 in advanced breas ...
Telomere repeat binding factor 2 (TRF2) binds directly to telomeres and preserves the structural integrity of chromosome ends. In vitro models sugge ...
Selective and effective killing ...
The cell surface receptor tissue factor (TF) is regarded as a common but specific target on angiogenic tumor vascular endothelial cells (VECs) and t ...
Pathways mediating the effects ...
Invasion and metastasis of aggressive breast cancer cells are the final and fatal steps during cancer progression. Clinically, there are still limit ...
A systematic review of the rela ...
The estrogen signal is mediated by the estrogen receptor (ER). The specific role of ER-beta, a second ER, in breast carcinogenesis is not known. A n ...
Estrogen levels act as a rheost ...
A large proportion of breast cancers expresses the estrogen receptor alpha (ERa) and are dependent on estrogens for their proliferation and survival ...